Mechanisms of synergism between gemcitabine and cisplatin.
van Moorsel
C J
CJ
Department of Medical Oncology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands.
Veerman
G
G
Vermorken
J B
JB
Voorn
D A
DA
Kroep
J R
JR
Bergman
A M
AM
Pinedo
H M
HM
Peters
G J
GJ
D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects / Q000493:pharmacokinetics / Q000633:toxicity*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D002945:Cisplatin / Q000009:adverse effects / Q000633:toxicity*; D004273:DNA, Neoplasm / Q000096:biosynthesis; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000633:toxicity; D004357:Drug Synergism; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms; D012334:RNA, Neoplasm / Q000096:biosynthesis; D014407:Tumor Cells, Cultured; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D004273:DNA, Neoplasm; D012334:RNA, Neoplasm; D003841:Deoxycytidine; D002945:Cisplatin; D000093542:Gemcitabine